However, only a few studies [14–17] evaluating the role of the ABO blood type in the prevalence of NETs in multiple endocrine neoplasia type 1 (MEN1) and Von Hippel-Lindau (VHL) disease, two inherited endocrine tumor syndromes, have been published thus far. This evidence concerns the gene ABO and multiple endocrine neoplasia type 1.